Yongsheng Li
Oncology · with Wu · 2020–2021
A researcher in the Science corpus: 2 papers; trusts 2 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Oncology — 100 citations into it
- Molecular Biology — 90 citations into it
- Pulmonary and Respiratory Medicine — 31 citations into it
Whom Yongsheng Li trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from Yongsheng Li's perspective
Ordered by how strongly the researchers Yongsheng Li trusts endorse each paper. Same corpus, a different order for every researcher.
- Identification of genotype-selective antitumor agents using synthetic lethal chemical screening in engineered human tumor cells. (Cancer Cell)
- Regulation of Ferroptotic Cancer Cell Death by GPX4 (Cell)
- Pharmacological inhibition of cystine–glutamate exchange induces endoplasmic reticulum stress and ferroptosis (eLife)
- Acsl4 Dictates Ferroptosis Sensitivity by Shaping Cellular Lipid Composition (Nature Chemical Biology)
- Activation of the p62-Keap1-NRF2 Pathway Protects against Ferroptosis in Hepatocellular Carcinoma Cells (Hepatology)
- Synthetic lethal screening identifies compounds activating iron-dependent, nonapoptotic cell death in oncogenic-RAS-harboring cancer cells. (Chemistry and Biology)
- RAS–RAF–MEK-dependent oxidative cell death involving voltage-dependent anion channels (Nature)
- T cell lipid peroxidation induces ferroptosis and prevents immunity to infection (Journal of Experimental Medicine)
- Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice (Nature Cell Biology)
- Peroxidation of polyunsaturated fatty acids by lipoxygenases drives ferroptosis (Proceedings of the National Academy of Sciences of the United States of America)
Their papers
- Inflammation and tumor progression: signaling pathways and targeted intervention (2021) — 2,418 citations
- The interaction between ferroptosis and lipid metabolism in cancer (2020) — 621 citations